Global Lung Cancer Liquid Biopsy Market Research Report 2025(Status and Outlook)
Report Overview
Lung cancer liquid biopsy is a non-invasive diagnostic test that involves analyzing biomarkers, such as circulating tumor cells, cell-free DNA, and exosomes, in a patient's blood sample to detect the presence of lung cancer. This innovative approach enables healthcare providers to identify specific genetic mutations associated with lung cancer, monitor disease progression, and personalize treatment plans for patients. By providing a less invasive alternative to traditional tissue biopsies, lung cancer liquid biopsy offers a promising solution for early detection and precision medicine in the management of lung cancer.
The market for lung cancer liquid biopsy is experiencing significant growth driven by several key factors. Firstly, the rising incidence of lung cancer globally, coupled with the increasing awareness of the importance of early detection and personalized treatment, is fueling the demand for non-invasive diagnostic solutions like liquid biopsy. Secondly, advancements in technology, such as next-generation sequencing and digital PCR, have enhanced the sensitivity and specificity of liquid biopsy tests, making them more reliable for detecting genetic mutations in lung cancer patients. Additionally, the growing investments in research and development by biotechnology and pharmaceutical companies to innovate new liquid biopsy products further contribute to the expansion of the market.
Moreover, the shift towards precision medicine and targeted therapies in oncology is driving the adoption of lung cancer liquid biopsy as a valuable tool for guiding treatment decisions. By providing real-time information on tumor dynamics and treatment response, liquid biopsy helps oncologists tailor therapy regimens to individual patients, improving clinical outcomes and overall survival rates. Furthermore, the increasing collaborations between diagnostic companies, research institutions, and healthcare providers to validate the clinical utility of liquid biopsy in lung cancer management are expected to accelerate market growth. In conclusion, the market for lung cancer liquid biopsy is poised for continued expansion as it offers a non-invasive, accurate, and personalized approach to diagnosing and treating lung cancer patients.
This report provides a deep insight into the global Lung Cancer Liquid Biopsy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Liquid Biopsy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Liquid Biopsy market in any manner.
Global Lung Cancer Liquid Biopsy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Market Segmentation (by Type)
Exosomes and RNA
CTCs and ctDNA
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Liquid Biopsy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Lung cancer liquid biopsy is a non-invasive diagnostic test that involves analyzing biomarkers, such as circulating tumor cells, cell-free DNA, and exosomes, in a patient's blood sample to detect the presence of lung cancer. This innovative approach enables healthcare providers to identify specific genetic mutations associated with lung cancer, monitor disease progression, and personalize treatment plans for patients. By providing a less invasive alternative to traditional tissue biopsies, lung cancer liquid biopsy offers a promising solution for early detection and precision medicine in the management of lung cancer.
The market for lung cancer liquid biopsy is experiencing significant growth driven by several key factors. Firstly, the rising incidence of lung cancer globally, coupled with the increasing awareness of the importance of early detection and personalized treatment, is fueling the demand for non-invasive diagnostic solutions like liquid biopsy. Secondly, advancements in technology, such as next-generation sequencing and digital PCR, have enhanced the sensitivity and specificity of liquid biopsy tests, making them more reliable for detecting genetic mutations in lung cancer patients. Additionally, the growing investments in research and development by biotechnology and pharmaceutical companies to innovate new liquid biopsy products further contribute to the expansion of the market.
Moreover, the shift towards precision medicine and targeted therapies in oncology is driving the adoption of lung cancer liquid biopsy as a valuable tool for guiding treatment decisions. By providing real-time information on tumor dynamics and treatment response, liquid biopsy helps oncologists tailor therapy regimens to individual patients, improving clinical outcomes and overall survival rates. Furthermore, the increasing collaborations between diagnostic companies, research institutions, and healthcare providers to validate the clinical utility of liquid biopsy in lung cancer management are expected to accelerate market growth. In conclusion, the market for lung cancer liquid biopsy is poised for continued expansion as it offers a non-invasive, accurate, and personalized approach to diagnosing and treating lung cancer patients.
This report provides a deep insight into the global Lung Cancer Liquid Biopsy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Liquid Biopsy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Liquid Biopsy market in any manner.
Global Lung Cancer Liquid Biopsy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Market Segmentation (by Type)
Exosomes and RNA
CTCs and ctDNA
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Lung Cancer Liquid Biopsy Market
- Overview of the regional outlook of the Lung Cancer Liquid Biopsy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Liquid Biopsy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Lung Cancer Liquid Biopsy
1.2 Key Market Segments
1.2.1 Lung Cancer Liquid Biopsy Segment by Type
1.2.2 Lung Cancer Liquid Biopsy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER LIQUID BIOPSY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lung Cancer Liquid Biopsy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Lung Cancer Liquid Biopsy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER LIQUID BIOPSY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Lung Cancer Liquid Biopsy Product Life Cycle
3.3 Global Lung Cancer Liquid Biopsy Sales by Manufacturers (2020-2025)
3.4 Global Lung Cancer Liquid Biopsy Revenue Market Share by Manufacturers (2020-2025)
3.5 Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Lung Cancer Liquid Biopsy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Lung Cancer Liquid Biopsy Sales Sites, Area Served, Product Type
3.8 Lung Cancer Liquid Biopsy Market Competitive Situation and Trends
3.8.1 Lung Cancer Liquid Biopsy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Lung Cancer Liquid Biopsy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER LIQUID BIOPSY INDUSTRY CHAIN ANALYSIS
4.1 Lung Cancer Liquid Biopsy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER LIQUID BIOPSY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 PEST Analysis
5.6.1 Industry Policies Analysis
5.6.2 Economic Environment Analysis
5.6.3 Social Environment Analysis
5.6.4 Technological Environment Analysis
5.7 Global Lung Cancer Liquid Biopsy Market Porter's Five Forces Analysis
5.7.1 Global Trade Frictions
5.7.2 Global Trade Frictions and Their Impacts to Lung Cancer Liquid Biopsy Market
5.8 ESG Ratings of Leading Companies
6 LUNG CANCER LIQUID BIOPSY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Liquid Biopsy Sales Market Share by Type (2020-2025)
6.3 Global Lung Cancer Liquid Biopsy Market Size Market Share by Type (2020-2025)
6.4 Global Lung Cancer Liquid Biopsy Price by Type (2020-2025)
7 LUNG CANCER LIQUID BIOPSY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Liquid Biopsy Market Sales by Application (2020-2025)
7.3 Global Lung Cancer Liquid Biopsy Market Size (M USD) by Application (2020-2025)
7.4 Global Lung Cancer Liquid Biopsy Sales Growth Rate by Application (2020-2025)
8 LUNG CANCER LIQUID BIOPSY MARKET SALES BY REGION
8.1 Global Lung Cancer Liquid Biopsy Sales by Region
8.1.1 Global Lung Cancer Liquid Biopsy Sales by Region
8.1.2 Global Lung Cancer Liquid Biopsy Sales Market Share by Region
8.2 Global Lung Cancer Liquid Biopsy Market Size by Region
8.2.1 Global Lung Cancer Liquid Biopsy Market Size by Region
8.2.2 Global Lung Cancer Liquid Biopsy Market Size Market Share by Region
8.3 North America
8.3.1 North America Lung Cancer Liquid Biopsy Sales by Country
8.3.2 North America Lung Cancer Liquid Biopsy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Lung Cancer Liquid Biopsy Sales by Country
8.4.2 Europe Lung Cancer Liquid Biopsy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Lung Cancer Liquid Biopsy Sales by Region
8.5.2 Asia Pacific Lung Cancer Liquid Biopsy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Lung Cancer Liquid Biopsy Sales by Country
8.6.2 South America Lung Cancer Liquid Biopsy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Lung Cancer Liquid Biopsy Sales by Region
8.7.2 Middle East and Africa Lung Cancer Liquid Biopsy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LUNG CANCER LIQUID BIOPSY MARKET PRODUCTION BY REGION
9.1 Global Production of Lung Cancer Liquid Biopsy by Region(2020-2025)
9.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Region (2020-2025)
9.3 Global Lung Cancer Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Lung Cancer Liquid Biopsy Production
9.4.1 North America Lung Cancer Liquid Biopsy Production Growth Rate (2020-2025)
9.4.2 North America Lung Cancer Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Lung Cancer Liquid Biopsy Production
9.5.1 Europe Lung Cancer Liquid Biopsy Production Growth Rate (2020-2025)
9.5.2 Europe Lung Cancer Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Lung Cancer Liquid Biopsy Production (2020-2025)
9.6.1 Japan Lung Cancer Liquid Biopsy Production Growth Rate (2020-2025)
9.6.2 Japan Lung Cancer Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Lung Cancer Liquid Biopsy Production (2020-2025)
9.7.1 China Lung Cancer Liquid Biopsy Production Growth Rate (2020-2025)
9.7.2 China Lung Cancer Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 RainDanceTechnologies
10.1.1 RainDanceTechnologies Basic Information
10.1.2 RainDanceTechnologies Lung Cancer Liquid Biopsy Product Overview
10.1.3 RainDanceTechnologies Lung Cancer Liquid Biopsy Product Market Performance
10.1.4 RainDanceTechnologies Business Overview
10.1.5 RainDanceTechnologies SWOT Analysis
10.1.6 RainDanceTechnologies Recent Developments
10.2 Biocartis
10.2.1 Biocartis Basic Information
10.2.2 Biocartis Lung Cancer Liquid Biopsy Product Overview
10.2.3 Biocartis Lung Cancer Liquid Biopsy Product Market Performance
10.2.4 Biocartis Business Overview
10.2.5 Biocartis SWOT Analysis
10.2.6 Biocartis Recent Developments
10.3 Qiagen
10.3.1 Qiagen Basic Information
10.3.2 Qiagen Lung Cancer Liquid Biopsy Product Overview
10.3.3 Qiagen Lung Cancer Liquid Biopsy Product Market Performance
10.3.4 Qiagen Business Overview
10.3.5 Qiagen SWOT Analysis
10.3.6 Qiagen Recent Developments
10.4 Guardant Health
10.4.1 Guardant Health Basic Information
10.4.2 Guardant Health Lung Cancer Liquid Biopsy Product Overview
10.4.3 Guardant Health Lung Cancer Liquid Biopsy Product Market Performance
10.4.4 Guardant Health Business Overview
10.4.5 Guardant Health Recent Developments
10.5 MDxHealth
10.5.1 MDxHealth Basic Information
10.5.2 MDxHealth Lung Cancer Liquid Biopsy Product Overview
10.5.3 MDxHealth Lung Cancer Liquid Biopsy Product Market Performance
10.5.4 MDxHealth Business Overview
10.5.5 MDxHealth Recent Developments
10.6 Pathway Genomics
10.6.1 Pathway Genomics Basic Information
10.6.2 Pathway Genomics Lung Cancer Liquid Biopsy Product Overview
10.6.3 Pathway Genomics Lung Cancer Liquid Biopsy Product Market Performance
10.6.4 Pathway Genomics Business Overview
10.6.5 Pathway Genomics Recent Developments
10.7 NeoGenomics Laboraories
10.7.1 NeoGenomics Laboraories Basic Information
10.7.2 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Product Overview
10.7.3 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Product Market Performance
10.7.4 NeoGenomics Laboraories Business Overview
10.7.5 NeoGenomics Laboraories Recent Developments
10.8 Sysmex Inostics
10.8.1 Sysmex Inostics Basic Information
10.8.2 Sysmex Inostics Lung Cancer Liquid Biopsy Product Overview
10.8.3 Sysmex Inostics Lung Cancer Liquid Biopsy Product Market Performance
10.8.4 Sysmex Inostics Business Overview
10.8.5 Sysmex Inostics Recent Developments
10.9 Cynvenio
10.9.1 Cynvenio Basic Information
10.9.2 Cynvenio Lung Cancer Liquid Biopsy Product Overview
10.9.3 Cynvenio Lung Cancer Liquid Biopsy Product Market Performance
10.9.4 Cynvenio Business Overview
10.9.5 Cynvenio Recent Developments
10.10 Menarini Silicon Biosystems
10.10.1 Menarini Silicon Biosystems Basic Information
10.10.2 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Product Overview
10.10.3 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Product Market Performance
10.10.4 Menarini Silicon Biosystems Business Overview
10.10.5 Menarini Silicon Biosystems Recent Developments
10.11 Adaptive Biotechnologies
10.11.1 Adaptive Biotechnologies Basic Information
10.11.2 Adaptive Biotechnologies Lung Cancer Liquid Biopsy Product Overview
10.11.3 Adaptive Biotechnologies Lung Cancer Liquid Biopsy Product Market Performance
10.11.4 Adaptive Biotechnologies Business Overview
10.11.5 Adaptive Biotechnologies Recent Developments
10.12 Biocept
10.12.1 Biocept Basic Information
10.12.2 Biocept Lung Cancer Liquid Biopsy Product Overview
10.12.3 Biocept Lung Cancer Liquid Biopsy Product Market Performance
10.12.4 Biocept Business Overview
10.12.5 Biocept Recent Developments
10.13 Angle plc
10.13.1 Angle plc Basic Information
10.13.2 Angle plc Lung Cancer Liquid Biopsy Product Overview
10.13.3 Angle plc Lung Cancer Liquid Biopsy Product Market Performance
10.13.4 Angle plc Business Overview
10.13.5 Angle plc Recent Developments
11 LUNG CANCER LIQUID BIOPSY MARKET FORECAST BY REGION
11.1 Global Lung Cancer Liquid Biopsy Market Size Forecast
11.2 Global Lung Cancer Liquid Biopsy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Lung Cancer Liquid Biopsy Market Size Forecast by Country
11.2.3 Asia Pacific Lung Cancer Liquid Biopsy Market Size Forecast by Region
11.2.4 South America Lung Cancer Liquid Biopsy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Lung Cancer Liquid Biopsy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Lung Cancer Liquid Biopsy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Lung Cancer Liquid Biopsy by Type (2026-2033)
12.1.2 Global Lung Cancer Liquid Biopsy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Lung Cancer Liquid Biopsy by Type (2026-2033)
12.2 Global Lung Cancer Liquid Biopsy Market Forecast by Application (2026-2033)
12.2.1 Global Lung Cancer Liquid Biopsy Sales (K Units) Forecast by Application
12.2.2 Global Lung Cancer Liquid Biopsy Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Lung Cancer Liquid Biopsy
1.2 Key Market Segments
1.2.1 Lung Cancer Liquid Biopsy Segment by Type
1.2.2 Lung Cancer Liquid Biopsy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER LIQUID BIOPSY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lung Cancer Liquid Biopsy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Lung Cancer Liquid Biopsy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER LIQUID BIOPSY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Lung Cancer Liquid Biopsy Product Life Cycle
3.3 Global Lung Cancer Liquid Biopsy Sales by Manufacturers (2020-2025)
3.4 Global Lung Cancer Liquid Biopsy Revenue Market Share by Manufacturers (2020-2025)
3.5 Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Lung Cancer Liquid Biopsy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Lung Cancer Liquid Biopsy Sales Sites, Area Served, Product Type
3.8 Lung Cancer Liquid Biopsy Market Competitive Situation and Trends
3.8.1 Lung Cancer Liquid Biopsy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Lung Cancer Liquid Biopsy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER LIQUID BIOPSY INDUSTRY CHAIN ANALYSIS
4.1 Lung Cancer Liquid Biopsy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER LIQUID BIOPSY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 PEST Analysis
5.6.1 Industry Policies Analysis
5.6.2 Economic Environment Analysis
5.6.3 Social Environment Analysis
5.6.4 Technological Environment Analysis
5.7 Global Lung Cancer Liquid Biopsy Market Porter's Five Forces Analysis
5.7.1 Global Trade Frictions
5.7.2 Global Trade Frictions and Their Impacts to Lung Cancer Liquid Biopsy Market
5.8 ESG Ratings of Leading Companies
6 LUNG CANCER LIQUID BIOPSY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Liquid Biopsy Sales Market Share by Type (2020-2025)
6.3 Global Lung Cancer Liquid Biopsy Market Size Market Share by Type (2020-2025)
6.4 Global Lung Cancer Liquid Biopsy Price by Type (2020-2025)
7 LUNG CANCER LIQUID BIOPSY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Liquid Biopsy Market Sales by Application (2020-2025)
7.3 Global Lung Cancer Liquid Biopsy Market Size (M USD) by Application (2020-2025)
7.4 Global Lung Cancer Liquid Biopsy Sales Growth Rate by Application (2020-2025)
8 LUNG CANCER LIQUID BIOPSY MARKET SALES BY REGION
8.1 Global Lung Cancer Liquid Biopsy Sales by Region
8.1.1 Global Lung Cancer Liquid Biopsy Sales by Region
8.1.2 Global Lung Cancer Liquid Biopsy Sales Market Share by Region
8.2 Global Lung Cancer Liquid Biopsy Market Size by Region
8.2.1 Global Lung Cancer Liquid Biopsy Market Size by Region
8.2.2 Global Lung Cancer Liquid Biopsy Market Size Market Share by Region
8.3 North America
8.3.1 North America Lung Cancer Liquid Biopsy Sales by Country
8.3.2 North America Lung Cancer Liquid Biopsy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Lung Cancer Liquid Biopsy Sales by Country
8.4.2 Europe Lung Cancer Liquid Biopsy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Lung Cancer Liquid Biopsy Sales by Region
8.5.2 Asia Pacific Lung Cancer Liquid Biopsy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Lung Cancer Liquid Biopsy Sales by Country
8.6.2 South America Lung Cancer Liquid Biopsy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Lung Cancer Liquid Biopsy Sales by Region
8.7.2 Middle East and Africa Lung Cancer Liquid Biopsy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LUNG CANCER LIQUID BIOPSY MARKET PRODUCTION BY REGION
9.1 Global Production of Lung Cancer Liquid Biopsy by Region(2020-2025)
9.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Region (2020-2025)
9.3 Global Lung Cancer Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Lung Cancer Liquid Biopsy Production
9.4.1 North America Lung Cancer Liquid Biopsy Production Growth Rate (2020-2025)
9.4.2 North America Lung Cancer Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Lung Cancer Liquid Biopsy Production
9.5.1 Europe Lung Cancer Liquid Biopsy Production Growth Rate (2020-2025)
9.5.2 Europe Lung Cancer Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Lung Cancer Liquid Biopsy Production (2020-2025)
9.6.1 Japan Lung Cancer Liquid Biopsy Production Growth Rate (2020-2025)
9.6.2 Japan Lung Cancer Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Lung Cancer Liquid Biopsy Production (2020-2025)
9.7.1 China Lung Cancer Liquid Biopsy Production Growth Rate (2020-2025)
9.7.2 China Lung Cancer Liquid Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 RainDanceTechnologies
10.1.1 RainDanceTechnologies Basic Information
10.1.2 RainDanceTechnologies Lung Cancer Liquid Biopsy Product Overview
10.1.3 RainDanceTechnologies Lung Cancer Liquid Biopsy Product Market Performance
10.1.4 RainDanceTechnologies Business Overview
10.1.5 RainDanceTechnologies SWOT Analysis
10.1.6 RainDanceTechnologies Recent Developments
10.2 Biocartis
10.2.1 Biocartis Basic Information
10.2.2 Biocartis Lung Cancer Liquid Biopsy Product Overview
10.2.3 Biocartis Lung Cancer Liquid Biopsy Product Market Performance
10.2.4 Biocartis Business Overview
10.2.5 Biocartis SWOT Analysis
10.2.6 Biocartis Recent Developments
10.3 Qiagen
10.3.1 Qiagen Basic Information
10.3.2 Qiagen Lung Cancer Liquid Biopsy Product Overview
10.3.3 Qiagen Lung Cancer Liquid Biopsy Product Market Performance
10.3.4 Qiagen Business Overview
10.3.5 Qiagen SWOT Analysis
10.3.6 Qiagen Recent Developments
10.4 Guardant Health
10.4.1 Guardant Health Basic Information
10.4.2 Guardant Health Lung Cancer Liquid Biopsy Product Overview
10.4.3 Guardant Health Lung Cancer Liquid Biopsy Product Market Performance
10.4.4 Guardant Health Business Overview
10.4.5 Guardant Health Recent Developments
10.5 MDxHealth
10.5.1 MDxHealth Basic Information
10.5.2 MDxHealth Lung Cancer Liquid Biopsy Product Overview
10.5.3 MDxHealth Lung Cancer Liquid Biopsy Product Market Performance
10.5.4 MDxHealth Business Overview
10.5.5 MDxHealth Recent Developments
10.6 Pathway Genomics
10.6.1 Pathway Genomics Basic Information
10.6.2 Pathway Genomics Lung Cancer Liquid Biopsy Product Overview
10.6.3 Pathway Genomics Lung Cancer Liquid Biopsy Product Market Performance
10.6.4 Pathway Genomics Business Overview
10.6.5 Pathway Genomics Recent Developments
10.7 NeoGenomics Laboraories
10.7.1 NeoGenomics Laboraories Basic Information
10.7.2 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Product Overview
10.7.3 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Product Market Performance
10.7.4 NeoGenomics Laboraories Business Overview
10.7.5 NeoGenomics Laboraories Recent Developments
10.8 Sysmex Inostics
10.8.1 Sysmex Inostics Basic Information
10.8.2 Sysmex Inostics Lung Cancer Liquid Biopsy Product Overview
10.8.3 Sysmex Inostics Lung Cancer Liquid Biopsy Product Market Performance
10.8.4 Sysmex Inostics Business Overview
10.8.5 Sysmex Inostics Recent Developments
10.9 Cynvenio
10.9.1 Cynvenio Basic Information
10.9.2 Cynvenio Lung Cancer Liquid Biopsy Product Overview
10.9.3 Cynvenio Lung Cancer Liquid Biopsy Product Market Performance
10.9.4 Cynvenio Business Overview
10.9.5 Cynvenio Recent Developments
10.10 Menarini Silicon Biosystems
10.10.1 Menarini Silicon Biosystems Basic Information
10.10.2 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Product Overview
10.10.3 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Product Market Performance
10.10.4 Menarini Silicon Biosystems Business Overview
10.10.5 Menarini Silicon Biosystems Recent Developments
10.11 Adaptive Biotechnologies
10.11.1 Adaptive Biotechnologies Basic Information
10.11.2 Adaptive Biotechnologies Lung Cancer Liquid Biopsy Product Overview
10.11.3 Adaptive Biotechnologies Lung Cancer Liquid Biopsy Product Market Performance
10.11.4 Adaptive Biotechnologies Business Overview
10.11.5 Adaptive Biotechnologies Recent Developments
10.12 Biocept
10.12.1 Biocept Basic Information
10.12.2 Biocept Lung Cancer Liquid Biopsy Product Overview
10.12.3 Biocept Lung Cancer Liquid Biopsy Product Market Performance
10.12.4 Biocept Business Overview
10.12.5 Biocept Recent Developments
10.13 Angle plc
10.13.1 Angle plc Basic Information
10.13.2 Angle plc Lung Cancer Liquid Biopsy Product Overview
10.13.3 Angle plc Lung Cancer Liquid Biopsy Product Market Performance
10.13.4 Angle plc Business Overview
10.13.5 Angle plc Recent Developments
11 LUNG CANCER LIQUID BIOPSY MARKET FORECAST BY REGION
11.1 Global Lung Cancer Liquid Biopsy Market Size Forecast
11.2 Global Lung Cancer Liquid Biopsy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Lung Cancer Liquid Biopsy Market Size Forecast by Country
11.2.3 Asia Pacific Lung Cancer Liquid Biopsy Market Size Forecast by Region
11.2.4 South America Lung Cancer Liquid Biopsy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Lung Cancer Liquid Biopsy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Lung Cancer Liquid Biopsy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Lung Cancer Liquid Biopsy by Type (2026-2033)
12.1.2 Global Lung Cancer Liquid Biopsy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Lung Cancer Liquid Biopsy by Type (2026-2033)
12.2 Global Lung Cancer Liquid Biopsy Market Forecast by Application (2026-2033)
12.2.1 Global Lung Cancer Liquid Biopsy Sales (K Units) Forecast by Application
12.2.2 Global Lung Cancer Liquid Biopsy Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Liquid Biopsy Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Liquid Biopsy Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Lung Cancer Liquid Biopsy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Lung Cancer Liquid Biopsy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Lung Cancer Liquid Biopsy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biopsy as of 2024)
Table 10. Global Market Lung Cancer Liquid Biopsy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Lung Cancer Liquid Biopsy Sales Sites and Area Served
Table 12. Manufacturers Lung Cancer Liquid Biopsy Product Type
Table 13. Global Lung Cancer Liquid Biopsy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Lung Cancer Liquid Biopsy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Lung Cancer Liquid Biopsy Sales by Type (K Units)
Table 25. Global Lung Cancer Liquid Biopsy Market Size by Type (M USD)
Table 26. Global Lung Cancer Liquid Biopsy Sales (K Units) by Type (2020-2025)
Table 27. Global Lung Cancer Liquid Biopsy Sales Market Share by Type (2020-2025)
Table 28. Global Lung Cancer Liquid Biopsy Market Size (M USD) by Type (2020-2025)
Table 29. Global Lung Cancer Liquid Biopsy Market Size Share by Type (2020-2025)
Table 30. Global Lung Cancer Liquid Biopsy Price (USD/Unit) by Type (2020-2025)
Table 31. Global Lung Cancer Liquid Biopsy Sales (K Units) by Application
Table 32. Global Lung Cancer Liquid Biopsy Market Size by Application
Table 33. Global Lung Cancer Liquid Biopsy Sales by Application (2020-2025) & (K Units)
Table 34. Global Lung Cancer Liquid Biopsy Sales Market Share by Application (2020-2025)
Table 35. Global Lung Cancer Liquid Biopsy Market Size by Application (2020-2025) & (M USD)
Table 36. Global Lung Cancer Liquid Biopsy Market Share by Application (2020-2025)
Table 37. Global Lung Cancer Liquid Biopsy Sales Growth Rate by Application (2020-2025)
Table 38. Global Lung Cancer Liquid Biopsy Sales by Region (2020-2025) & (K Units)
Table 39. Global Lung Cancer Liquid Biopsy Sales Market Share by Region (2020-2025)
Table 40. Global Lung Cancer Liquid Biopsy Market Size by Region (2020-2025) & (M USD)
Table 41. Global Lung Cancer Liquid Biopsy Market Size Market Share by Region (2020-2025)
Table 42. North America Lung Cancer Liquid Biopsy Sales by Country (2020-2025) & (K Units)
Table 43. North America Lung Cancer Liquid Biopsy Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Lung Cancer Liquid Biopsy Sales by Country (2020-2025) & (K Units)
Table 45. Europe Lung Cancer Liquid Biopsy Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Lung Cancer Liquid Biopsy Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Lung Cancer Liquid Biopsy Market Size by Region (2020-2025) & (M USD)
Table 48. South America Lung Cancer Liquid Biopsy Sales by Country (2020-2025) & (K Units)
Table 49. South America Lung Cancer Liquid Biopsy Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Lung Cancer Liquid Biopsy Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Lung Cancer Liquid Biopsy Market Size by Region (2020-2025) & (M USD)
Table 52. Global Lung Cancer Liquid Biopsy Production (K Units) by Region(2020-2025)
Table 53. Global Lung Cancer Liquid Biopsy Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Lung Cancer Liquid Biopsy Revenue Market Share by Region (2020-2025)
Table 55. Global Lung Cancer Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Lung Cancer Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Lung Cancer Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Lung Cancer Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Lung Cancer Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. RainDanceTechnologies Basic Information
Table 61. RainDanceTechnologies Lung Cancer Liquid Biopsy Product Overview
Table 62. RainDanceTechnologies Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. RainDanceTechnologies Business Overview
Table 64. RainDanceTechnologies SWOT Analysis
Table 65. RainDanceTechnologies Recent Developments
Table 66. Biocartis Basic Information
Table 67. Biocartis Lung Cancer Liquid Biopsy Product Overview
Table 68. Biocartis Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Biocartis Business Overview
Table 70. Biocartis SWOT Analysis
Table 71. Biocartis Recent Developments
Table 72. Qiagen Basic Information
Table 73. Qiagen Lung Cancer Liquid Biopsy Product Overview
Table 74. Qiagen Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Qiagen Business Overview
Table 76. Qiagen SWOT Analysis
Table 77. Qiagen Recent Developments
Table 78. Guardant Health Basic Information
Table 79. Guardant Health Lung Cancer Liquid Biopsy Product Overview
Table 80. Guardant Health Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Guardant Health Business Overview
Table 82. Guardant Health Recent Developments
Table 83. MDxHealth Basic Information
Table 84. MDxHealth Lung Cancer Liquid Biopsy Product Overview
Table 85. MDxHealth Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. MDxHealth Business Overview
Table 87. MDxHealth Recent Developments
Table 88. Pathway Genomics Basic Information
Table 89. Pathway Genomics Lung Cancer Liquid Biopsy Product Overview
Table 90. Pathway Genomics Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Pathway Genomics Business Overview
Table 92. Pathway Genomics Recent Developments
Table 93. NeoGenomics Laboraories Basic Information
Table 94. NeoGenomics Laboraories Lung Cancer Liquid Biopsy Product Overview
Table 95. NeoGenomics Laboraories Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. NeoGenomics Laboraories Business Overview
Table 97. NeoGenomics Laboraories Recent Developments
Table 98. Sysmex Inostics Basic Information
Table 99. Sysmex Inostics Lung Cancer Liquid Biopsy Product Overview
Table 100. Sysmex Inostics Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Sysmex Inostics Business Overview
Table 102. Sysmex Inostics Recent Developments
Table 103. Cynvenio Basic Information
Table 104. Cynvenio Lung Cancer Liquid Biopsy Product Overview
Table 105. Cynvenio Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Cynvenio Business Overview
Table 107. Cynvenio Recent Developments
Table 108. Menarini Silicon Biosystems Basic Information
Table 109. Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Product Overview
Table 110. Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Menarini Silicon Biosystems Business Overview
Table 112. Menarini Silicon Biosystems Recent Developments
Table 113. Adaptive Biotechnologies Basic Information
Table 114. Adaptive Biotechnologies Lung Cancer Liquid Biopsy Product Overview
Table 115. Adaptive Biotechnologies Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Adaptive Biotechnologies Business Overview
Table 117. Adaptive Biotechnologies Recent Developments
Table 118. Biocept Basic Information
Table 119. Biocept Lung Cancer Liquid Biopsy Product Overview
Table 120. Biocept Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Biocept Business Overview
Table 122. Biocept Recent Developments
Table 123. Angle plc Basic Information
Table 124. Angle plc Lung Cancer Liquid Biopsy Product Overview
Table 125. Angle plc Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Angle plc Business Overview
Table 127. Angle plc Recent Developments
Table 128. Global Lung Cancer Liquid Biopsy Sales Forecast by Region (2026-2033) & (K Units)
Table 129. Global Lung Cancer Liquid Biopsy Market Size Forecast by Region (2026-2033) & (M USD)
Table 130. North America Lung Cancer Liquid Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 131. North America Lung Cancer Liquid Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 132. Europe Lung Cancer Liquid Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 133. Europe Lung Cancer Liquid Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Asia Pacific Lung Cancer Liquid Biopsy Sales Forecast by Region (2026-2033) & (K Units)
Table 135. Asia Pacific Lung Cancer Liquid Biopsy Market Size Forecast by Region (2026-2033) & (M USD)
Table 136. South America Lung Cancer Liquid Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 137. South America Lung Cancer Liquid Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Middle East and Africa Lung Cancer Liquid Biopsy Sales Forecast by Country (2026-2033) & (Units)
Table 139. Middle East and Africa Lung Cancer Liquid Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Global Lung Cancer Liquid Biopsy Sales Forecast by Type (2026-2033) & (K Units)
Table 141. Global Lung Cancer Liquid Biopsy Market Size Forecast by Type (2026-2033) & (M USD)
Table 142. Global Lung Cancer Liquid Biopsy Price Forecast by Type (2026-2033) & (USD/Unit)
Table 143. Global Lung Cancer Liquid Biopsy Sales (K Units) Forecast by Application (2026-2033)
Table 144. Global Lung Cancer Liquid Biopsy Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Liquid Biopsy Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Liquid Biopsy Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Lung Cancer Liquid Biopsy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Lung Cancer Liquid Biopsy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Lung Cancer Liquid Biopsy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biopsy as of 2024)
Table 10. Global Market Lung Cancer Liquid Biopsy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Lung Cancer Liquid Biopsy Sales Sites and Area Served
Table 12. Manufacturers Lung Cancer Liquid Biopsy Product Type
Table 13. Global Lung Cancer Liquid Biopsy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Lung Cancer Liquid Biopsy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Lung Cancer Liquid Biopsy Sales by Type (K Units)
Table 25. Global Lung Cancer Liquid Biopsy Market Size by Type (M USD)
Table 26. Global Lung Cancer Liquid Biopsy Sales (K Units) by Type (2020-2025)
Table 27. Global Lung Cancer Liquid Biopsy Sales Market Share by Type (2020-2025)
Table 28. Global Lung Cancer Liquid Biopsy Market Size (M USD) by Type (2020-2025)
Table 29. Global Lung Cancer Liquid Biopsy Market Size Share by Type (2020-2025)
Table 30. Global Lung Cancer Liquid Biopsy Price (USD/Unit) by Type (2020-2025)
Table 31. Global Lung Cancer Liquid Biopsy Sales (K Units) by Application
Table 32. Global Lung Cancer Liquid Biopsy Market Size by Application
Table 33. Global Lung Cancer Liquid Biopsy Sales by Application (2020-2025) & (K Units)
Table 34. Global Lung Cancer Liquid Biopsy Sales Market Share by Application (2020-2025)
Table 35. Global Lung Cancer Liquid Biopsy Market Size by Application (2020-2025) & (M USD)
Table 36. Global Lung Cancer Liquid Biopsy Market Share by Application (2020-2025)
Table 37. Global Lung Cancer Liquid Biopsy Sales Growth Rate by Application (2020-2025)
Table 38. Global Lung Cancer Liquid Biopsy Sales by Region (2020-2025) & (K Units)
Table 39. Global Lung Cancer Liquid Biopsy Sales Market Share by Region (2020-2025)
Table 40. Global Lung Cancer Liquid Biopsy Market Size by Region (2020-2025) & (M USD)
Table 41. Global Lung Cancer Liquid Biopsy Market Size Market Share by Region (2020-2025)
Table 42. North America Lung Cancer Liquid Biopsy Sales by Country (2020-2025) & (K Units)
Table 43. North America Lung Cancer Liquid Biopsy Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Lung Cancer Liquid Biopsy Sales by Country (2020-2025) & (K Units)
Table 45. Europe Lung Cancer Liquid Biopsy Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Lung Cancer Liquid Biopsy Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Lung Cancer Liquid Biopsy Market Size by Region (2020-2025) & (M USD)
Table 48. South America Lung Cancer Liquid Biopsy Sales by Country (2020-2025) & (K Units)
Table 49. South America Lung Cancer Liquid Biopsy Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Lung Cancer Liquid Biopsy Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Lung Cancer Liquid Biopsy Market Size by Region (2020-2025) & (M USD)
Table 52. Global Lung Cancer Liquid Biopsy Production (K Units) by Region(2020-2025)
Table 53. Global Lung Cancer Liquid Biopsy Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Lung Cancer Liquid Biopsy Revenue Market Share by Region (2020-2025)
Table 55. Global Lung Cancer Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Lung Cancer Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Lung Cancer Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Lung Cancer Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Lung Cancer Liquid Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. RainDanceTechnologies Basic Information
Table 61. RainDanceTechnologies Lung Cancer Liquid Biopsy Product Overview
Table 62. RainDanceTechnologies Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. RainDanceTechnologies Business Overview
Table 64. RainDanceTechnologies SWOT Analysis
Table 65. RainDanceTechnologies Recent Developments
Table 66. Biocartis Basic Information
Table 67. Biocartis Lung Cancer Liquid Biopsy Product Overview
Table 68. Biocartis Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Biocartis Business Overview
Table 70. Biocartis SWOT Analysis
Table 71. Biocartis Recent Developments
Table 72. Qiagen Basic Information
Table 73. Qiagen Lung Cancer Liquid Biopsy Product Overview
Table 74. Qiagen Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Qiagen Business Overview
Table 76. Qiagen SWOT Analysis
Table 77. Qiagen Recent Developments
Table 78. Guardant Health Basic Information
Table 79. Guardant Health Lung Cancer Liquid Biopsy Product Overview
Table 80. Guardant Health Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Guardant Health Business Overview
Table 82. Guardant Health Recent Developments
Table 83. MDxHealth Basic Information
Table 84. MDxHealth Lung Cancer Liquid Biopsy Product Overview
Table 85. MDxHealth Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. MDxHealth Business Overview
Table 87. MDxHealth Recent Developments
Table 88. Pathway Genomics Basic Information
Table 89. Pathway Genomics Lung Cancer Liquid Biopsy Product Overview
Table 90. Pathway Genomics Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Pathway Genomics Business Overview
Table 92. Pathway Genomics Recent Developments
Table 93. NeoGenomics Laboraories Basic Information
Table 94. NeoGenomics Laboraories Lung Cancer Liquid Biopsy Product Overview
Table 95. NeoGenomics Laboraories Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. NeoGenomics Laboraories Business Overview
Table 97. NeoGenomics Laboraories Recent Developments
Table 98. Sysmex Inostics Basic Information
Table 99. Sysmex Inostics Lung Cancer Liquid Biopsy Product Overview
Table 100. Sysmex Inostics Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Sysmex Inostics Business Overview
Table 102. Sysmex Inostics Recent Developments
Table 103. Cynvenio Basic Information
Table 104. Cynvenio Lung Cancer Liquid Biopsy Product Overview
Table 105. Cynvenio Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Cynvenio Business Overview
Table 107. Cynvenio Recent Developments
Table 108. Menarini Silicon Biosystems Basic Information
Table 109. Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Product Overview
Table 110. Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Menarini Silicon Biosystems Business Overview
Table 112. Menarini Silicon Biosystems Recent Developments
Table 113. Adaptive Biotechnologies Basic Information
Table 114. Adaptive Biotechnologies Lung Cancer Liquid Biopsy Product Overview
Table 115. Adaptive Biotechnologies Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Adaptive Biotechnologies Business Overview
Table 117. Adaptive Biotechnologies Recent Developments
Table 118. Biocept Basic Information
Table 119. Biocept Lung Cancer Liquid Biopsy Product Overview
Table 120. Biocept Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Biocept Business Overview
Table 122. Biocept Recent Developments
Table 123. Angle plc Basic Information
Table 124. Angle plc Lung Cancer Liquid Biopsy Product Overview
Table 125. Angle plc Lung Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Angle plc Business Overview
Table 127. Angle plc Recent Developments
Table 128. Global Lung Cancer Liquid Biopsy Sales Forecast by Region (2026-2033) & (K Units)
Table 129. Global Lung Cancer Liquid Biopsy Market Size Forecast by Region (2026-2033) & (M USD)
Table 130. North America Lung Cancer Liquid Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 131. North America Lung Cancer Liquid Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 132. Europe Lung Cancer Liquid Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 133. Europe Lung Cancer Liquid Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Asia Pacific Lung Cancer Liquid Biopsy Sales Forecast by Region (2026-2033) & (K Units)
Table 135. Asia Pacific Lung Cancer Liquid Biopsy Market Size Forecast by Region (2026-2033) & (M USD)
Table 136. South America Lung Cancer Liquid Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 137. South America Lung Cancer Liquid Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Middle East and Africa Lung Cancer Liquid Biopsy Sales Forecast by Country (2026-2033) & (Units)
Table 139. Middle East and Africa Lung Cancer Liquid Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Global Lung Cancer Liquid Biopsy Sales Forecast by Type (2026-2033) & (K Units)
Table 141. Global Lung Cancer Liquid Biopsy Market Size Forecast by Type (2026-2033) & (M USD)
Table 142. Global Lung Cancer Liquid Biopsy Price Forecast by Type (2026-2033) & (USD/Unit)
Table 143. Global Lung Cancer Liquid Biopsy Sales (K Units) Forecast by Application (2026-2033)
Table 144. Global Lung Cancer Liquid Biopsy Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Lung Cancer Liquid Biopsy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Liquid Biopsy Market Size (M USD), 2024-2033
Figure 5. Global Lung Cancer Liquid Biopsy Market Size (M USD) (2020-2033)
Figure 6. Global Lung Cancer Liquid Biopsy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Liquid Biopsy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Lung Cancer Liquid Biopsy Product Life Cycle
Figure 13. Lung Cancer Liquid Biopsy Sales Share by Manufacturers in 2024
Figure 14. Global Lung Cancer Liquid Biopsy Revenue Share by Manufacturers in 2024
Figure 15. Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Lung Cancer Liquid Biopsy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Liquid Biopsy Revenue in 2024
Figure 18. Industry Chain Map of Lung Cancer Liquid Biopsy
Figure 19. Global Lung Cancer Liquid Biopsy Market PESTE Analysis
Figure 20. Global Lung Cancer Liquid Biopsy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Lung Cancer Liquid Biopsy Market Share by Type
Figure 27. Sales Market Share of Lung Cancer Liquid Biopsy by Type (2020-2025)
Figure 28. Sales Market Share of Lung Cancer Liquid Biopsy by Type in 2024
Figure 29. Market Size Share of Lung Cancer Liquid Biopsy by Type (2020-2025)
Figure 30. Market Size Share of Lung Cancer Liquid Biopsy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Lung Cancer Liquid Biopsy Market Share by Application
Figure 33. Global Lung Cancer Liquid Biopsy Sales Market Share by Application (2020-2025)
Figure 34. Global Lung Cancer Liquid Biopsy Sales Market Share by Application in 2024
Figure 35. Global Lung Cancer Liquid Biopsy Market Share by Application (2020-2025)
Figure 36. Global Lung Cancer Liquid Biopsy Market Share by Application in 2024
Figure 37. Global Lung Cancer Liquid Biopsy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Lung Cancer Liquid Biopsy Sales Market Share by Region (2020-2025)
Figure 39. Global Lung Cancer Liquid Biopsy Market Size Market Share by Region (2020-2025)
Figure 40. North America Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Lung Cancer Liquid Biopsy Sales Market Share by Country in 2024
Figure 43. North America Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Lung Cancer Liquid Biopsy Market Size Market Share by Country in 2024
Figure 45. U.S. Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Lung Cancer Liquid Biopsy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Lung Cancer Liquid Biopsy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Lung Cancer Liquid Biopsy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Lung Cancer Liquid Biopsy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Lung Cancer Liquid Biopsy Sales Market Share by Country in 2024
Figure 53. Europe Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Lung Cancer Liquid Biopsy Market Size Market Share by Country in 2024
Figure 55. Germany Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Lung Cancer Liquid Biopsy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Lung Cancer Liquid Biopsy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Lung Cancer Liquid Biopsy Market Size Market Share by Region in 2024
Figure 68. China Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Lung Cancer Liquid Biopsy Sales and Growth Rate (K Units)
Figure 79. South America Lung Cancer Liquid Biopsy Sales Market Share by Country in 2024
Figure 80. South America Lung Cancer Liquid Biopsy Market Size and Growth Rate (M USD)
Figure 81. South America Lung Cancer Liquid Biopsy Market Size Market Share by Country in 2024
Figure 82. Brazil Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Lung Cancer Liquid Biopsy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Lung Cancer Liquid Biopsy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Lung Cancer Liquid Biopsy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Lung Cancer Liquid Biopsy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Lung Cancer Liquid Biopsy Production Market Share by Region (2020-2025)
Figure 103. North America Lung Cancer Liquid Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Lung Cancer Liquid Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Lung Cancer Liquid Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Lung Cancer Liquid Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Lung Cancer Liquid Biopsy Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Lung Cancer Liquid Biopsy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Lung Cancer Liquid Biopsy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Lung Cancer Liquid Biopsy Market Share Forecast by Type (2026-2033)
Figure 111. Global Lung Cancer Liquid Biopsy Sales Forecast by Application (2026-2033)
Figure 112. Global Lung Cancer Liquid Biopsy Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Lung Cancer Liquid Biopsy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Liquid Biopsy Market Size (M USD), 2024-2033
Figure 5. Global Lung Cancer Liquid Biopsy Market Size (M USD) (2020-2033)
Figure 6. Global Lung Cancer Liquid Biopsy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Liquid Biopsy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Lung Cancer Liquid Biopsy Product Life Cycle
Figure 13. Lung Cancer Liquid Biopsy Sales Share by Manufacturers in 2024
Figure 14. Global Lung Cancer Liquid Biopsy Revenue Share by Manufacturers in 2024
Figure 15. Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Lung Cancer Liquid Biopsy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Liquid Biopsy Revenue in 2024
Figure 18. Industry Chain Map of Lung Cancer Liquid Biopsy
Figure 19. Global Lung Cancer Liquid Biopsy Market PESTE Analysis
Figure 20. Global Lung Cancer Liquid Biopsy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Lung Cancer Liquid Biopsy Market Share by Type
Figure 27. Sales Market Share of Lung Cancer Liquid Biopsy by Type (2020-2025)
Figure 28. Sales Market Share of Lung Cancer Liquid Biopsy by Type in 2024
Figure 29. Market Size Share of Lung Cancer Liquid Biopsy by Type (2020-2025)
Figure 30. Market Size Share of Lung Cancer Liquid Biopsy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Lung Cancer Liquid Biopsy Market Share by Application
Figure 33. Global Lung Cancer Liquid Biopsy Sales Market Share by Application (2020-2025)
Figure 34. Global Lung Cancer Liquid Biopsy Sales Market Share by Application in 2024
Figure 35. Global Lung Cancer Liquid Biopsy Market Share by Application (2020-2025)
Figure 36. Global Lung Cancer Liquid Biopsy Market Share by Application in 2024
Figure 37. Global Lung Cancer Liquid Biopsy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Lung Cancer Liquid Biopsy Sales Market Share by Region (2020-2025)
Figure 39. Global Lung Cancer Liquid Biopsy Market Size Market Share by Region (2020-2025)
Figure 40. North America Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Lung Cancer Liquid Biopsy Sales Market Share by Country in 2024
Figure 43. North America Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Lung Cancer Liquid Biopsy Market Size Market Share by Country in 2024
Figure 45. U.S. Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Lung Cancer Liquid Biopsy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Lung Cancer Liquid Biopsy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Lung Cancer Liquid Biopsy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Lung Cancer Liquid Biopsy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Lung Cancer Liquid Biopsy Sales Market Share by Country in 2024
Figure 53. Europe Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Lung Cancer Liquid Biopsy Market Size Market Share by Country in 2024
Figure 55. Germany Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Lung Cancer Liquid Biopsy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Lung Cancer Liquid Biopsy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Lung Cancer Liquid Biopsy Market Size Market Share by Region in 2024
Figure 68. China Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Lung Cancer Liquid Biopsy Sales and Growth Rate (K Units)
Figure 79. South America Lung Cancer Liquid Biopsy Sales Market Share by Country in 2024
Figure 80. South America Lung Cancer Liquid Biopsy Market Size and Growth Rate (M USD)
Figure 81. South America Lung Cancer Liquid Biopsy Market Size Market Share by Country in 2024
Figure 82. Brazil Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Lung Cancer Liquid Biopsy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Lung Cancer Liquid Biopsy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Lung Cancer Liquid Biopsy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Lung Cancer Liquid Biopsy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Lung Cancer Liquid Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Lung Cancer Liquid Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Lung Cancer Liquid Biopsy Production Market Share by Region (2020-2025)
Figure 103. North America Lung Cancer Liquid Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Lung Cancer Liquid Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Lung Cancer Liquid Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Lung Cancer Liquid Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Lung Cancer Liquid Biopsy Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Lung Cancer Liquid Biopsy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Lung Cancer Liquid Biopsy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Lung Cancer Liquid Biopsy Market Share Forecast by Type (2026-2033)
Figure 111. Global Lung Cancer Liquid Biopsy Sales Forecast by Application (2026-2033)
Figure 112. Global Lung Cancer Liquid Biopsy Market Share Forecast by Application (2026-2033)
